ALZ-801 (ALZ801; BLU-8499; NRM-8499) is an orally bioavailable, small-molecule inhibitor of beta amyloid (Aβ) oligomer formation with the potential for treating Alzheimer's disease (AD). ALZ-801 is a prodrug of tramiprosate with improved PK/pharmacokinetic properties and gastrointestinal tolerability.